The Hemodynamic Response to Prolonged Dobutamine Infusion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01042873
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01042873
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT01042873. Allocation not applicable; no masking; primary purpose other. Start 2010-01 (registry gives no type); primary completion 2020-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Hemodynamic Response to Prolonged Dobutamine Infusion
- Condition
- Healthy
- Condition
- Heart Failure
- Intervention (Drug)
- 3 hours intravenous dobutamine
- Lead sponsor
- Hadassah Medical Organization
Record details
- Record id
cardio:ct-nct01042873- Content hash
59085db6059e447b2ed8a4b709d8fa48b746cf448ca73549ec5210654d88feb3